MedTrace Logo

Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator

NCT03876054 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-01-07

No results posted yet for this study

Summary

The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.

Conditions

Interventions

DEVICE

Dorsal root ganglion stimulation (DRG)

Subjects will be implanted with market-released Abbott DRG system

DEVICE

Spinal cord stimulation (SCS)

Subjects will be implanted with market-released Abbott SCS systems

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Devyani Nanduri · Abbott Medical Devices Neuromodulation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-13
Primary Completion
2029-06-30
Completion
2029-12-31
FDA Device
Yes

Countries

  • United States
  • Australia
  • Belgium
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03876054 on ClinicalTrials.gov